whatisbiotechnology.org Report : Visit Site

Technical data of the whatisbiotechnology.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host whatisbiotechnology.org. Currently, hosted in United Kingdom and its service provider is Fast Hosts Ltd .

the related websites

101greatgoals.com propertyweek.com open.ac.uk aarp.org nice.org.uk ebrd.com hermes.com bbc.co.uk ikea.com guinnessworldrecords.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

what is biotechnology? facebook twitter support wib home community exhibitions people places sciences timeline whatisbiotechnology is a content-led community that brings together the stories about the sciences, people and places that have enabled biotechnology to transform medicine and the world we live in today click here if you would prefer a plain version of this page women in biotechnology we are pleased to publish some reflections from women about what they see as the most important change for women in the life sciences and healthcare sector in recent years. click here to see their comments and contribute your own reflections . this is part of an ongoing public engagement project to champion the contributions of women in the biomedical sciences. click here to find out more about this project . find out about some of the hidden women at the cutting edge of the science by visiting our profiles of some of the women who have helped shape biotechnology . click here to see a timeline of initiatives implemented to promote gender equality in the biomedical sciences . this day in biotechnology the following events took place on this day (11th june) in years past: 1912-06-11t00:00:00+0000 harvard university, university of colorado keith roberts porter was born in yarmough, nova scotia, canada (1912) porter was a canadian biologist. he is renowned for having developed many of the techniques and experimental approaches that underpinned the founding of cellular biology as a new discipline in biomedical research. critically he developed the first electron microscope techniques to get high resolution images of cells and tissues. in 1945 he published the first electron microgragh of a complete animal cell. his other major contributions to the field was his development a roller-flask for culturing cells and helping to invent an instrument for getting ultra-thin slices of tissue for microscopy. sciences: cell . the sciences visit our science section to explore some of the most important sciences behind biotechnology and medicine including: transgenic animals . transgenic animals are those that have had their genes deliberately altered to give them specific characteristics they would not otherwise possess naturally. such genetically modified animals play a pivotal role in determining the genetic cause of disease and the discovery and testing of new treatments. click here to learn more about transgenic animals . click here to browse all the sciences special exhibitions ever wanted to tread in the footsteps of scientists to understand how they come up with new ideas in the laboratory and translate these into new products for patients? you can do this by visiting our special exhibitions section. using photographs, laboratory notebooks and other historical sources, these exhibitions bring to life some of this process. see for yourself some of the ups and downs the scientists have faced along the way. the path to dna sequencing: the life and work of frederick sanger one of the most important tools in biotechnology and medicine today is dna sequencing, invented by frederick sanger, a british biochemist. this exhibition follows the journey of sanger starting in the 1940s when he began looking for ways to decipher the composition of proteins through to his development of dna sequencing in the 1970s. come see the time-consuming and painstaking steps sanger went through to perfect the dna sequencing technique and the many different areas of medicine where dna sequencing is now being applied all the way from the human genome project through to cancer and antimicrobial resistance. click here to view the exhibition click here to view the exhibition the life story of a monoclonal antibody a third of all new medicines introduced into the world today are monoclonal antibodies, many of which go on to become blockbuster drugs. this exhibition is the story of how one specific monoclonal antibody, the oldest humanised monoclonal antibody created with therapeutic potential, moved from the laboratory bench through to the clinic and the impact it has had on patients' lives. the antibody, which originated from the cambridge pathology family of antibodies, started life in 1979 not as a therapeutic, but as a laboratory tool for understanding the immune system. within a short time, however, the antibody, yth66.9, was being used to improve the success of bone marrow transplants and as a treatment for leukaemia, lymphoma, vasculitis, organ transplants and multiple sclerosis. highlighting the many twists and turns that this monoclonal antibody took over time, this exhibition explores the multitude of actors and events involved in the making of a biotechnology drug. click here to view the exhibition click here to view the exhibition a healthcare revolution in the making: the story of césar milstein and monoclonal antibodies today monoclonal antibodies are indispensable to medicine. they are not only used as therapeutics, comprising six out of ten of the best selling drugs in the world, but are also critical to unravelling the pathways of disease and integral components of diagnostic tests. yet, the story of how these unsung microscopic heroes came into the world and helped change healthcare remains largely untold. the journey of monoclonal antibodies all started when an argentinian émigré called césar milstein arrived at the laboratory of molecular biology in cambridge, the same laboratory where watson and crick discovered the structure of dna. this exhibition tells the story of how milstein came to develop monoclonal antibodies and demonstrated their clinical application for the first time. click here to view the exhibition click here to view the exhibition the people exploring the lives and works of the leading people from across the world like brigitte askonas (pictured) whose efforts have helped build biotechnology into a world changing science. brigitte askonas (born: 1923-04-01t00:00:00+0000 1923 - died: 2013-01-09t00:00:00+0000 2013) askonas co-developed one of the first systems for the cloning of antibody-forming b cells in vivo, some of the earliest monoclonal antibodies. she was also one of the first scientists to isolate and clone virus specific t lymphocytes, laying the foundation for defining different influenza sub-sets and improving vaccines. click here to learn more about brigitte askonas . click here to browse all the people the places exploring the places and institutions, and people working in them, across the world like basel institute of immunology (pictured) where the science of biotechnology has been developed. a leading centre for immunological research from 1971 to 2000, the basel institute of immunology helped lay the groundwork for the development of monoclonal antibodies. click here to learn more about basel institute of immunology . click here to browse all the places timeline an ever-growing list of events, currently 1418 events, that have contributed to the growth of biotechnology. click here to browse the timeline . for timelines for specific sciences click here: antibodies , crispr-cas9 , genetics , gene therapy , immunotherapy , monoclonal antibodies , vaccines , virology . for timelines for specific places click here: cambridge university , harvard university , the laboratory of molecular biology , the pasteur institute , rockefeller university , the wistar institute . for timelines for specific people click here: cesar milstein , fred sanger , donall thomas , herman waldmann . the untold story of monoclonal antibodies yale university press 2015-06-30 9780300167733 yale university press has announced the publication of the lock and key of medicine: monoclonal antibodies and the transformation of healthcare by lara v. marks ( yale university press , amazon ). forty years ago, viable monoclonal antibodies, imperceptibly small 'magic bullets', became available for the first time. first produced in 1975 by césar milstein and georges köhler at the laboratory of molecular biology in cambridge, england (where watson and crick unraveled the structure of dna), mabs have had a phenomenally far-reaching effect on our society and daily life. the lock and key of medicine is the first book to tell the extraordinary yet unheralded history of monoclonal antibodies, or mabs. though unfamiliar to most nonscientists, these microscopic protein molecules are everywhere, quietly shaping our lives and healthcare. they have radically changed understandings of the pathways of disease, enabling faster, cheaper, and more accurate clinical diagnostic testing. historian of medicine lara v. marks recounts the risks and opposition that a daring handful of individuals faced while discovering and developing mabs, and she addresses the related scientific, medical, technological, business, and social challenges that arose. she offers a saga of entrepreneurs who ultimately changed the healthcare landscape and brought untold relief to millions of patients. even so, controversies over mabs remain, which the author explores through the current debates on their cost-effectiveness. engineering health: how biotechnology changed medicine the royal society of chemistry 2017-10-27 978-1-78262-084-6 the royal society of chemistry has announced the publication of engineering health: how biotechnology changed medicine edited by lara v. marks ( the royal society of chemistry ). written in an accessible style, experts trace the development of biotechnologies like stem cells, gene therapy, monoclonal antibodies and synthetic biology and how these are reshaping the diagnostic and therapeutic landscape. building on material from this website, this book shows the challenges behind the application of biotechnology to medicine. with medicines increasingly shifting from small organic molecules to large, complex structures, such as therapeutic proteins, drugs have become more difficult to make, administer and regulate. this book will intrigue anyone interested in the past, present and future of how we engineer better health for ourselves. the rise of biotechnology has major implications for how and where drugs are manufactured, the cost of medicine and how far society is prepared to go to combat disease. celebrating the first publication of monoclonal antibodies it is now over 40 years since césar milstein and georges kohler published their technique for producing monoclonal antibodies. to celebrate the occasion we invite you to watch the film un fuegito about the life and work of milstein, produced by ana fraile, pulpofilms. the film, which you can find on vimeo.com , has been released to help raise funds for a new educational film to promote greater understanding about monoclonal antibodies and how they have transformed the lives of millions of patients across the world. the debate: genome editing scientists have recently begun to adopt a new technique for genetic engineering, called crispr-cas9, in a wide number fields ranging from agriculture to medicine. part of its attraction is that it permits genetic engineering on an unprecedented scale and at a very low cost. the technique is already being used in a variety of fields ( click here for more information about crispr-cas9 ). but because of its potential to modify dna in human embryos, it has prompted calls for a public debate about where the technology should be applied. researchers working with whatisbiotechnology.org recently ran a pilot survey to gather people's views on the new technology. dr lara marks, managing editor of whatisbiotechnology.org and historian of medicine and dr silvia camporesi, bioethicist at king's college london, led the project. some 567 people contributed to the debate. the analysis of their contributions is available on this page . forthcoming projects we are working on a number of new and exciting projects with highly talented partners and collaborators that we plan to launch in the latter part of this year and next year. these projects include an examination of the role of women in healthcare and the life sciences, a project about conquering hepatitis b and an in-depth exploration of the new sciences around cancer immunotherapy. click here to find out more about the new projects that we are currently working on . facebook twitter suport us contact us contact us about advisory board terms © 2018

URL analysis for whatisbiotechnology.org

http://www.whatisbiotechnology.org/index.php/women/reflections/reflections-from-women-in-the-life-sciences-and-healthcare
http://www.whatisbiotechnology.org/index.php/timeline/person/sanger
http://www.whatisbiotechnology.org/index.php/timeline/science/genetics
http://www.whatisbiotechnology.org/index.php/timeline/science/vaccine
http://www.whatisbiotechnology.org/index.php/exhibitions/campath
http://www.whatisbiotechnology.org/index.php/women
http://www.whatisbiotechnology.org/index.php/timeline/place/rockefeller
http://www.whatisbiotechnology.org/index.php/terms
http://www.whatisbiotechnology.org/index.php/timeline/place/cambridge
http://www.whatisbiotechnology.org/index.php/timeline/science/monoclonal%20antibodies
http://www.whatisbiotechnology.org/index.php/advisory
http://www.whatisbiotechnology.org/index.php/contact
http://www.whatisbiotechnology.org/index.php/timeline/person/milstein
http://www.whatisbiotechnology.org/index.php/timeline/place/harvard
http://www.whatisbiotechnology.org/index.php/exhibitions/sanger

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: WHATISBIOTECHNOLOGY.ORG
Registry Domain ID: D162726299-LROR
Registrar WHOIS Server:
Registrar URL: http://www.tucows.com
Updated Date: 2017-06-07T08:16:55Z
Creation Date: 2011-07-07T08:16:06Z
Registry Expiry Date: 2018-07-07T08:16:06Z
Registrar Registration Expiration Date:
Registrar: Tucows Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: C183367711-LROR
Registrant Name: Contact Privacy Inc. Customer 0131722485
Registrant Organization: Contact Privacy Inc. Customer 0131722485
Registrant Street: 96 Mowat Ave
Registrant City: Toronto
Registrant State/Province: ON
Registrant Postal Code: M6K 3M1
Registrant Country: CA
Registrant Phone: +1.4165385457
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID: C183367711-LROR
Admin Name: Contact Privacy Inc. Customer 0131722485
Admin Organization: Contact Privacy Inc. Customer 0131722485
Admin Street: 96 Mowat Ave
Admin City: Toronto
Admin State/Province: ON
Admin Postal Code: M6K 3M1
Admin Country: CA
Admin Phone: +1.4165385457
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID: C183367711-LROR
Tech Name: Contact Privacy Inc. Customer 0131722485
Tech Organization: Contact Privacy Inc. Customer 0131722485
Tech Street: 96 Mowat Ave
Tech City: Toronto
Tech State/Province: ON
Tech Postal Code: M6K 3M1
Tech Country: CA
Tech Phone: +1.4165385457
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: [email protected]
Name Server: NS1.LIVEDNS.CO.UK
Name Server: NS2.LIVEDNS.CO.UK
Name Server: NS3.LIVEDNS.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-09-28T20:18:14Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS whatisbiotechnology.org

  PORT 43

  TYPE domain

DOMAIN

  NAME whatisbiotechnology.org

  HANDLE D162726299-LROR

  CREATED 2011-07-07

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS1.LIVEDNS.CO.UK 213.171.192.250

  NS2.LIVEDNS.CO.UK 213.171.193.250

  NS3.LIVEDNS.CO.UK 213.171.192.254

OWNER

  HANDLE C183367711-LROR

  NAME Contact Privacy Inc. Customer 0131722485

  ORGANIZATION Contact Privacy Inc. Customer 0131722485

ADDRESS

STREET
96 Mowat Ave

  CITY Toronto

  STATE ON

  PCODE M6K 3M1

  COUNTRY CA

  PHONE +1.4165385457

  EMAIL [email protected]

ADMIN

  HANDLE C183367711-LROR

  NAME Contact Privacy Inc. Customer 0131722485

  ORGANIZATION Contact Privacy Inc. Customer 0131722485

ADDRESS

STREET
96 Mowat Ave

  CITY Toronto

  STATE ON

  PCODE M6K 3M1

  COUNTRY CA

  PHONE +1.4165385457

  EMAIL [email protected]

TECH

  HANDLE C183367711-LROR

  NAME Contact Privacy Inc. Customer 0131722485

  ORGANIZATION Contact Privacy Inc. Customer 0131722485

ADDRESS

STREET
96 Mowat Ave

  CITY Toronto

  STATE ON

  PCODE M6K 3M1

  COUNTRY CA

  PHONE +1.4165385457

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .